Current Issue - Silder
Current Issue: February 2022
This month's highlight articles
Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study
In this retrospective study of 248 patients with pT1b esophageal adenocarcinoma, a model was developed for prediction of metastasis after endoscopic resection and/or surgery. Risk factors for metastasis included submucosal invasion depth, lymphovascular invasion, and larger tumor size. These factors served as important predictors to guide subsequent treatment, for example salvage surgery.
Risk evaluation of duodenoscope-associated infections in the Netherlands calls for a heightened awareness of device-related infections: a systematic review
In this systematic literature review of all outbreaks in the Netherlands of duodenoscope-associated infection (DAI) during an 11-year study period, the authors confirmed three outbreaks across three medical centers, with a total of 21 confirmed cases. Based on an estimated number of 204 170 ERCPs performed during the study period, the minimum estimated DAI risk was 0.01%, or 1 case in every 10 000 ERCPs.
ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants
Despite the worldwide introduction of COVID-19 vaccinations, GI endoscopy still entails a significant risk of infection and morbidity from COVID-19, for both health care professionals (HCPs) and patients. Infection prevention and control has been shown to be dramatically effective in assuring their safety. This ESGE-ESGENA updated Position Statement aims to provide ongoing guidance during the pandemic to help assure the highest level of GI endoscopy care and protection against COVID-19 for our patients and HCPs. It is based upon the best available evidence in the current context of COVID-19 vaccines and SARS-CoV-2 viral variants.